Lyophilized preparations of melphalan flufenamide
The present invention is directed to lyophilized pharmaceutical preparations comprising melphalan flufenamide, or pharmaceutically acceptable salts thereof, methods for their preparation, compositions comprising the lyophilized pharmaceutical preparations and their use in the treatment of cancer.
1. A method for preparing a lyophilized pharmaceutical preparation that is directly soluble in a physiologically acceptable aqueous solution, said pharmaceutical preparation comprising melphalan flufenamide or a pharmaceutically acceptable salt thereof comprising the steps of:
(a) producing a solution containing melphalan flufenamide or a pharmaceutically acceptable salt thereof, an organic solvent and water by:
(i) dissolving melphalan flufenamide or a pharmaceutically acceptable salt thereof in an organic solvent or a mixture of an organic solvent and water; and
(ii) if an organic solvent is used in step (i), combining the solution obtained in step (a)(i) with water;
(b) combining the solution produced in step (a) with sucrose to obtain an aqueous solution of melphalan flufenamide or a pharmaceutically acceptable salt and sucrose in the organic solvent and water at a weight ratio (w/w) of melphalan flufenamide or pharmaceutically acceptable salt thereof to sucrose from about 1:25 to about 1:75; and
(c) subjecting the aqueous solution obtained in step (b) to lyophilization,
such that a lyophilized pharmaceutical preparation that is directly soluble in a physiologically acceptable aqueous solution and comprises melphalan flufenamide or a pharmaceutically acceptable salt thereof is obtained.
2. The method of claim 1 , wherein:
step (a) comprises producing a solution containing melphalan flufenamide hydrochloride (J1), an organic solvent and water by:
(i) dissolving J1 in an organic solvent or a mixture of an organic solvent and water; and
(ii) if an organic solvent is used in step (i), combining the solution obtained in step (a)(i) with water;
step (b) comprises combining the solution produced in step (a) with sucrose to obtain an aqueous solution of J1 and sucrose in the organic solvent and water at a weight ratio (w/w) of J1 to sucrose from about 1:25 to about 1:75; and
step (c) comprises subjecting the aqueous solution obtained in step (b) to lyophilization.
3. The method of claim 2 , wherein step (b) comprises combining the solution produced in step (a) with sucrose to obtain an aqueous solution of J1 and sucrose in the organic solvent and water at a weight ratio (w/w) of J1 to sucrose of about 1:50.
4. The method of claim 2 , wherein step (a)(i) comprises dissolving J1 in an organic solvent.
5. The method of claim 4 , wherein the organic solvent is tert-butanol.
6. The method of claim 5 , wherein the solution produced in step (a) has a volume ratio of tert-butanol and water of about 1:1.
7. The method of claim 4 , wherein step (a)(ii) comprises diluting the solution obtained in (a)(i) with water to achieve a J1 concentration of about 0.2-3.0 mg/ml.
8. The method of claim 7 , wherein the organic solvent is tert-butanol.
9. The method of claim 8 , wherein the solution produced in step (a) has a volume ratio of tert-butanol and water of about 1:1.
10. The method of claim 3 , wherein step (a)(i) comprises dissolving J1 in an organic solvent.
11. The method of claim 10 , wherein the organic solvent is tert-butanol.
12. The method of claim 11 , wherein the solution produced in step (a) has a volume ratio of tert-butanol and water of about 1:1.
13. The method of claim 10 , wherein step (a)(ii) comprises diluting the solution obtained in (a)(i) with water to achieve a J1 concentration of about 0.2-3.0 mg/ml.
14. The method of claim 13 , wherein the organic solvent is tert-butanol.
15. The method of claim 14 , wherein the solution produced in step (a) has a volume ratio of tert-butanol and water of about 1:1.
16. The method of claim 2 , wherein step (a)(i) comprises dissolving J1 in a mixture of an organic solvent and water.
17. The method of claim 16 , wherein the organic solvent is tert-butanol.
18. The method of claim 17 , wherein the volume ratio of tert-butanol and water in the mixture is about 1:1.
19. The method of claim 3 , wherein step (a)(i) comprises dissolving J1 in a mixture of an organic solvent and water.
20. The method of claim 19 , wherein the organic solvent is tert-butanol.
21. The method of claim 20 , wherein the volume ratio of tert-butanol and water in the mixture is about 1:1.
22. The method of claim 5 , wherein the sucrose combined with the solution produced in step (a) is in the form of an aqueous solution.
23. The method of claim 6 , wherein the sucrose combined with the solution produced in step (a) is in the form of an aqueous solution.
24. The method of claim 14 , wherein the sucrose combined with the solution produced in step (a) is in the form of an aqueous solution.
25. The method of claim 15 , wherein the sucrose combined with the solution produced in step (a) is in the form of an aqueous solution.
26. The method of claim 1 , in which sucrose is the sole excipient in the solution lyophilized in step (c).
27. The method of claim 5 , in which sucrose is the sole excipient in the solution lyophilized in step (c).
28. The method of claim 6 , in which sucrose is the sole excipient in the solution lyophilized in step (c).
29. The method of claim 14 , in which sucrose is the sole excipient in the solution lyophilized in step (c).
30. The method of claim 15 , in which sucrose is the sole excipient in the solution lyophilized in step (c).
31. The method of claim 1 , wherein the melphalan flufenamide or a pharmaceutically acceptable salt thereof is in the form of a pharmaceutically acceptable salt.
32. The method of claim 31 , in which sucrose is the sole excipient in the solution lyophilized in step (c).
33. The method of claim 31 , in which the organic solvent is tert-butanol.
34. The method of claim 32 , in which the organic solvent is tert-butanol.